ES2061641T3 - Agentes anti-tumorales. - Google Patents

Agentes anti-tumorales.

Info

Publication number
ES2061641T3
ES2061641T3 ES88302486T ES88302486T ES2061641T3 ES 2061641 T3 ES2061641 T3 ES 2061641T3 ES 88302486 T ES88302486 T ES 88302486T ES 88302486 T ES88302486 T ES 88302486T ES 2061641 T3 ES2061641 T3 ES 2061641T3
Authority
ES
Spain
Prior art keywords
alkyl
alkynyl
alcoxy
hydrogen
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88302486T
Other languages
English (en)
Inventor
Leslie Richard Hughes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NAT RES DEV
Imperial Chemical Industries Ltd
National Research Development Corp UK
Original Assignee
NAT RES DEV
Imperial Chemical Industries Ltd
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NAT RES DEV, Imperial Chemical Industries Ltd, National Research Development Corp UK filed Critical NAT RES DEV
Application granted granted Critical
Publication of ES2061641T3 publication Critical patent/ES2061641T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UNA QUINAZOLINA DE LA FORMULA (I), DONDE R1 ES ALQUILO, CICLOALQUILO,ALQUENILO, ALQUINILO, ALCOXI, ALQUILTIO, ARILO, ARILOXI, ARILTIO, ARILALQUILO, HALOGENO, HIDROXI O MERCAPTO O ALQUILO O ALCOXI SUSTITUIDO, DONDE R2 ES HIDROGENO, ALQUILO, ALQUENILO O ALQUINILO O ALQUILO O ALCANOILO SUSTITUIDO, DONDE AR ES FENILENO, NAFTILENO O HETEROCICLENO QUE NO ESTA SUSTITUIDO O LLEVA UNO O MAS SUSTITUYENTES; DONDE R3 ES TAL QUE R3-NH2 ES UN AMINOACIDO DONDE R4 ES HIGROGENO O ALQUILO, R5 ES HIDROGENO O ALQUILO; Y R6, R7 Y R8 ES HIDROGENO, HIDROXI, ALQUILO, ALCOXI, ALQUILTIO,ALQUILAMINO, DIALQUILAMINO, FENILO, HALOGENO, NITRO, CIANO O AMINO, O ALQUILO, ALCOXI O ALQUILTIO SUSTITUIDO; Y SIEMPRE QUE AL MENOS UNO DE R4, R5, R6, R7 Y R8 SEAN DISTINTOS DEL HIDROGENO; O UNA SAL FARMACEUTICAMENTE ACEPTABLE O SU ESTER. LOS COMPUESTOS POSEEN ACTIVIDAD ANTITUMORAL.
ES88302486T 1987-03-25 1988-03-22 Agentes anti-tumorales. Expired - Lifetime ES2061641T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878707053A GB8707053D0 (en) 1987-03-25 1987-03-25 Anti-tumour agents

Publications (1)

Publication Number Publication Date
ES2061641T3 true ES2061641T3 (es) 1994-12-16

Family

ID=10614570

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88302486T Expired - Lifetime ES2061641T3 (es) 1987-03-25 1988-03-22 Agentes anti-tumorales.

Country Status (17)

Country Link
US (1) US4981856A (es)
EP (1) EP0284338B1 (es)
JP (1) JP2577036B2 (es)
AT (1) ATE98956T1 (es)
AU (1) AU600105B2 (es)
CA (1) CA1301756C (es)
DE (1) DE3886435T2 (es)
DK (1) DK167013B1 (es)
ES (1) ES2061641T3 (es)
FI (1) FI881340A7 (es)
GB (2) GB8707053D0 (es)
GR (1) GR3010208T3 (es)
IL (1) IL85696A (es)
NO (1) NO881300L (es)
NZ (1) NZ224010A (es)
PT (1) PT87074B (es)
ZA (1) ZA881885B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
US5252573A (en) * 1988-12-15 1993-10-12 Imperial Chemical Industries Plc Anti-tumor agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
US5160727A (en) * 1990-02-13 1992-11-03 Warner-Lambert Company Tumor cell sensitization method using quinazolinedione derivatives
IL98167A0 (en) * 1990-05-30 1992-06-21 Ici Plc Anti-tumour quinazoline derivatives,processes for their preparation and pharmaceutical compositions comprising them
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
US5145854A (en) * 1991-11-27 1992-09-08 Nair Madhavan G 1-formyl-5,8,10-trideazafolates
GB9205320D0 (en) * 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
DE4421884A1 (de) 1994-06-23 1996-01-04 Hoechst Ag Verfahren zur Herstellung von Hydroxycarbonsäureaniliden
DE4427837A1 (de) 1994-08-05 1996-02-08 Hoechst Ag Verfahren zur Herstellung von O-Acylglykolsäureaniliden
DE19504225A1 (de) 1995-02-09 1996-08-14 Hoechst Ag Verfahren zur Herstellung von O-Acyloxycarbonsäureaniliden
US5739330A (en) * 1996-02-05 1998-04-14 Hoechst Celanese Corporation Process for preparing quinazolones
GB9904275D0 (en) 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
AU2002346471A1 (en) * 2001-11-20 2003-06-10 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
US7087418B2 (en) 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Pichia pastoris formate dehydrogenase and uses therefor
WO2003070701A2 (en) * 2002-02-15 2003-08-28 Cytokinetics, Inc. Syntheses of quinazolinones
US7214800B2 (en) * 2002-05-09 2007-05-08 Cytokinetics, Inc. Compounds, compositions, and methods
CA2485148A1 (en) * 2002-05-09 2003-11-20 Cytokinetics, Inc. Pyrimidinone compounds, compositions and methods
EP1513820A4 (en) * 2002-05-23 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
WO2003106426A1 (en) * 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
AU2003256805A1 (en) * 2002-07-23 2004-02-09 Cytokinetics, Inc. Compounds compositions and methods
US20040048853A1 (en) * 2002-08-21 2004-03-11 Gustave Bergnes Compounds, compositions, and methods
WO2004034972A2 (en) * 2002-09-30 2004-04-29 Cytokinetics, Inc. Compounds, compositions, and methods
GB0317631D0 (en) * 2003-07-28 2003-08-27 Btg Int Ltd Synthetic method
JP2007510652A (ja) * 2003-11-03 2007-04-26 サイトキネティクス・インコーポレーテッド ピリミジン−４−オン化合物、組成物、および方法
EP1680420A4 (en) * 2003-11-07 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1692112A4 (en) * 2003-12-08 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS, AND METHODS
AU2008268613A1 (en) * 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
MX2021012208A (es) 2013-10-04 2023-01-19 Infinity Pharmaceuticals Inc Compuestos heterocíclicos y usos de los mismos.
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
NZ724368A (en) 2014-03-19 2023-07-28 Infinity Pharmaceuticals Inc Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP4585268A3 (en) 2015-09-14 2025-10-15 Twelve Therapeutics, Inc. Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069468D1 (en) * 1979-12-19 1984-11-22 Nat Res Dev Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents

Also Published As

Publication number Publication date
NO881300D0 (no) 1988-03-24
GR3010208T3 (es) 1994-03-31
DK167013B1 (da) 1993-08-16
FI881340A0 (fi) 1988-03-21
GB8805982D0 (en) 1988-04-13
DE3886435T2 (de) 1994-04-14
NZ224010A (en) 1990-12-21
EP0284338A2 (en) 1988-09-28
EP0284338B1 (en) 1993-12-22
CA1301756C (en) 1992-05-26
GB8707053D0 (en) 1987-04-29
ZA881885B (en) 1988-09-26
US4981856A (en) 1991-01-01
EP0284338A3 (en) 1989-05-17
AU1327988A (en) 1988-09-29
DK168488D0 (da) 1988-03-25
AU600105B2 (en) 1990-08-02
DE3886435D1 (de) 1994-02-03
IL85696A (en) 1993-05-13
JPS63255270A (ja) 1988-10-21
DK168488A (da) 1988-09-26
NO881300L (no) 1988-09-26
GB2202847A (en) 1988-10-05
GB2202847B (en) 1990-06-06
ATE98956T1 (de) 1994-01-15
JP2577036B2 (ja) 1997-01-29
FI881340A7 (fi) 1988-09-26
PT87074B (pt) 1992-07-31
PT87074A (pt) 1988-04-01

Similar Documents

Publication Publication Date Title
ES2061641T3 (es) Agentes anti-tumorales.
ES2038170T3 (es) Procedimiento para preparar derivados de quinazolina utiles como agentes anti-tumorales.
ES2031513T3 (es) Quinazolindionas y piridopirimidinadionas.
PA8463501A1 (es) Derivados de acido hidroxamico como inhibidores de metaloproteasas de matriz (mmp)
ES2143487T3 (es) 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.
ES2143557T3 (es) Agentes de tranferencia de cadena alilica.
CO4940451A1 (es) Derivados de acido barbiturico con actividad antimetastica y antitumoral
ES2044982T3 (es) Un procedimiento para preparar un compuesto que inhibe las enzimas lipoxigenasas.
FI103884B1 (fi) Menetelmä farmaseuttisesti tehokkaiden guanidinokarbonyylisubstituoitujen isokinoliinien valmistamiseksi
ES2054630T3 (es) Peptidos antivirales y medios para tratar infecciones de herpes.
EP0254327A3 (en) N-n-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihydroquinazolinyl) oxyalkylamides and related compounds
ES2026669T3 (es) Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos.
ES8306750A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
AR041861A1 (es) Feniliso (tio) cianatos, procesos e intermediarios para su preparacion.
ES8601925A1 (es) Procedimiento para la preparacion de derivados de pirimidina.
ES484784A1 (es) Procedimiento para la obtencion de n-benzoil-n'-terc.-alco- xicarbonilfenil-(tio)ureas sustituidas, de efecto insectici-da
DK0640081T3 (da) Substituerede phenylcarbarmater og phenylurinstoffer, deres fremstilling og deres anvendelse som 5-HT4-antagonister
BR9914255A (pt) Derivados de indolina como agentes de proteção de luz
ES2117132T3 (es) Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral.
AR240859A2 (es) Composicion herbicida que contiene un derivado de difenil eter, dicho compuesto y procedimiento paraprepararlo
ES2032437T3 (es) Inmunoestimulantes heptanoil-glu-asp-ala-aminoacidos.
ES2180100T3 (es) Agentes antitumorales de tioxantenona.
ES8500896A1 (es) Procedimiento para la obtencion de 1-fenil-3-benzoil-(tio)-ureas
ES8303415A1 (es) Un procedimiento para la preparacion de nuevos derivados de 3-triazolo (4,5-6) (1,5) benzodiazepina.
EP0123861A3 (en) Ureum derivatives

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 284338

Country of ref document: ES